Sequana Medical Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
48
- Stock Symbol
-
SEQUA
- Share Price
-
$0.72
- (As of Tuesday Closing)
Sequana Medical General Information
Description
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
Contact Information
Website
www.sequanamedical.comCorporate Office
- Kortrijksesteenweg 1112
- 9051 Sint-Denijs-Westrem
- Belgium
Corporate Office
- Kortrijksesteenweg 1112
- 9051 Sint-Denijs-Westrem
- Belgium
Sequana Medical Timeline
Sequana Medical Stock Performance
As of 28-Apr-2026, Sequana Medical’s stock price is $0.72. Its current market cap is $56M with 77.6M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.72 | $0.74 | $0.53 - $1.88 | $56M | 77.6M | 233K | -$1.34 |
Sequana Medical Financials Summary
As of 30-Jun-2025, Sequana Medical has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 146,018 | 160,409 | 125,591 | 135,724 |
| Revenue | 0 | 114 | 771 | 970 |
| EBITDA | (43,126) | (44,498) | (31,865) | (30,685) |
| Net Income | (56,360) | (48,320) | (35,236) | (32,344) |
| Total Assets | 17,086 | 10,347 | 11,166 | 27,909 |
| Total Debt | 48,550 | 41,739 | 19,366 | 18,866 |
Sequana Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sequana Medical Comparisons
Industry
Financing
Details
Sequana Medical Competitors (22)
One of Sequana Medical’s 22 competitors is Endologix, a Corporation company based in Santa Rosa, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Endologix | Corporation | Santa Rosa, CA | ||||
| BioPro (Michigan) | Corporation | Port Huron, MI | ||||
| Merit Medical Systems | Corporation | South Jordan, UT | ||||
| Boston Scientific | Corporation | Marlborough, MA | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT |
Sequana Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sequana Medical Patents
Sequana Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024052770-A1 | Implantable pump system enhancements for use in conducting direct sodium removal therapy | Inactive | 06-Sep-2022 | ||
| WO-2024033880-A1 | Apparatus and methods for draining fluid from the thoracic duct | Inactive | 12-Aug-2022 | ||
| WO-2023214238-A1 | Formulations and methods for direct sodium removal in patients having heart failure and/or severe renal dysfunction | Inactive | 02-May-2022 | ||
| WO-2023148686-A1 | Implantable pump for direct sodium removal therapy having on-board analyte sensor | Inactive | 07-Feb-2022 | ||
| WO-2023126802-A1 | Implantable pump having infection monitoring feature | Inactive | 03-Jan-2022 | A61B5/4842 |
Sequana Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sequana Medical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sequana Medical ESG
Risk Overview
Risk Rating
Updated January, 31, 2024
31.87 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,942
Rank
Percentile
Healthcare
Industry
of 631
Rank
Percentile
Medical Devices
Subindustry
of 219
Rank
Percentile
Sequana Medical FAQs
-
When was Sequana Medical founded?
Sequana Medical was founded in 2006.
-
Where is Sequana Medical headquartered?
Sequana Medical is headquartered in Sint-Denijs-Westrem, Belgium.
-
What is the size of Sequana Medical?
Sequana Medical has 48 total employees.
-
What industry is Sequana Medical in?
Sequana Medical’s primary industry is Therapeutic Devices.
-
Is Sequana Medical a private or public company?
Sequana Medical is a Public company.
-
What is Sequana Medical’s stock symbol?
The ticker symbol for Sequana Medical is SEQUA.
-
What is the current stock price of Sequana Medical?
As of 28-Apr-2026 the stock price of Sequana Medical is $0.72.
-
What is the current market cap of Sequana Medical?
The current market capitalization of Sequana Medical is $56M.
-
Who are Sequana Medical’s competitors?
Endologix, BioPro (Michigan), Merit Medical Systems, Boston Scientific, and Spine Wave are some of the 22 competitors of Sequana Medical.
-
What is Sequana Medical’s annual earnings per share (EPS)?
Sequana Medical’s EPS for 12 months was -$1.34.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
